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ABSTRACT
Introduction: Minimally invasive nonsurgical techniques are gaining ground as alternatives to surgery
for the treatment of benign thyroid nodules. Here, we aimed at comparing patient satisfaction after
radiofrequency ablation (RFA) to that after surgery.
Methods: In this cross-sectional study, we recruited 126 patients treated with RFA and 84 treated with
surgery for a single benign thyroid nodule. All patients were contacted by phone call and were asked
the following questions: Are you satisfied with the symptom resolution?; Are you satisfied with the
cosmetic results?; Are you satisfied overall with the procedure?; Are you taking any medication for
your thyroid? Patients’ general characteristics were collected from our database.
Results: In the surgery group, there was a higher percentage of patients fully satisfied with the reso-
lution of nodule-related symptoms (p¼ .02). In the RFA group, there was a higher percentage of
patients fully satisfied with the cosmetic results (p¼ .001). In terms of overall satisfaction, there were
no differences between the groups (p¼ .26). Nevertheless, RFA led to differing results based on thy-
roid nodule function. In patients with nonfunctioning thyroid nodules, RFA was as effective as surgery
in terms of satisfaction with symptom resolution, while it was not in patients with autonomously func-
tioning thyroid nodules (AFTN).
Conclusion: Our data on postoperative patient satisfaction support the notion that both RFA and sur-
gery are valid therapeutic options for nonfunctioning thyroid nodules, while surgery should be still
preferred for AFTN.
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Minimally invasive nonsurgical techniques are gaining
ground as an alternative to surgery for the treatment of
benign thyroid nodules [1,2]. These techniques include
percutaneous sclerotherapy, which is usually performed
with ethanol, as well as thermal ablation techniques.
Percutaneous sclerotherapy with ethanol injection has been
the first ultrasound (US)-guided nonsurgical technique to be
used for the treatment of thyroid nodules, and it is now indi-
cated only for symptomatic thyroid cysts [3,4]. On the other
hand, thermal ablation procedures, which make the target
nodule shrink via heat generation [5], have been mostly
used to treat solid thyroid nodules. These techniques include
laser, radiofrequency and microwave ablation, as well as
high-intensity focused ultrasound [3,6].
Thus far, the thermal ablation techniques that have been
most widely used are laser and radiofrequency ablation (LA
and RFA, respectively). It is still a matter of debate whether
one is superior to the other [7]. Regarding their efficacy, LA
can reduce nodule volume by 40%–80% [2], while RFA can
reduce it by 50%–80% [2,8]. Although it may be perceived
that RFA is somehow superior to LA in reducing thyroid nod-
ule volume [9], Mauri et al. have demonstrated that RFA and
LA are similarly feasible, safe and effective in treating benign
thyroid nodules when performed by the same team [10]. In
other words, the operators’ experience seems to be a more
important indicator of treatment outcome than the ablation
technique in US-guided thermal ablations [11].
Recently, both LA and RFA have been included in the
American Association of Clinical Endocrinologists’ guidelines
as therapeutic options for symptomatic benign thyroid nod-
ules [12]. Nevertheless, for other authoritative medical soci-
eties [13], surgery remains the only therapy for symptomatic
benign thyroid nodules [13]. To date, only a few studies
have compared thermal ablations to surgery in patients with
benign thyroid nodules [14–16], highlighting several poten-
tial advantages of RFA over surgery. While these studies
have compared the efficacy, tolerability, cost and health-
related quality of life of RFA to surgery [14–16],
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postoperative patient satisfaction has been overlooked. The
current study aimed to compare RFA to surgery in terms of
patient satisfaction after 12months from the procedure.
Materials and methods
Population
This is a cross-sectional pilot study involving patients treated
with thyroid RFA (between March 2012 and March 2016) or
hemithyroidectomy (hEMItx; between March 2005 and March
2016). The inclusion criteria were the following: being treated
1.) due to a solitary benign thyroid nodule (Bethesda II/Thy2/
Tir2), 2.) at least one year before the survey and 3.) by the
same operator (radiologist or surgeon, respectively). The
benign nature of the nodules was assessed by fine needle
aspiration cytology [17]. Based on these criteria, we selected
126 patients previously treated with RFA (out of 159 RFA
procedures) and 84 patients who had undergone hemithyroi-
dectomy (out of 169 hemithyroidectomies). When contacted
by phone, 115 patients out of 126, in the RFA group, and 68
out of 84, in the surgery group, completed the survey
(Figure 1). The RFA group was composed of 83 patients with
nonfunctioning thyroid nodules and 32 patients with autono-
mously functioning thyroid nodules (AFTN). The surgery
group contained 44 patients with nonfunctioning thyroid
nodules and 24 patients with AFTN. The response rate to our
survey was 91.3% for patients treated with RFA and 81% for
patients treated with surgery (p¼ .04 vs RFA). The missing
rate, which was lower than 20%, was acceptable in both
groups [18,19]. For all patients that completed the survey,
the following characteristics were collected from our data-
base: baseline age, sex, thyroid nodule features, thyroid func-
tion, calcitonin, autoimmunity, and post-procedure thyroid
nodule features and overall complications. It must be noted
that in the RFA group, complications were classified accord-
ing to the criteria defined by the Society of Interventional
Radiology [20], where major complications are events that
lead to substantial morbidity and disability that increase the
level of care and all other complications are considered
minor. Given that surgical complications are not usually clas-
sified like those that follow RFA [21,22], we compared the
rate of overall complications between the groups. The proto-
col of this study was approved by the Institutional Review
Board of the Azienda Ospedaliera – Ospedali Riuniti di
Trieste [14], and all patients had given written informed con-
sent prior to the procedures.
Thyroid nodule features
The thyroid nodule features that we took into account were
nodule maximum diameter (mm), nodule volume (mL), type
of nodule and vascularity. As previously reported [23], the
formula that we used for calculating nodule volume was
pabc/6 (where ‘a’ is the maximum diameter of the nodule,
and ‘b’ and ‘c’ are the other two perpendicular diameters).
Volume (V) reduction was calculated as follows:
(initial–finalV/initialV)100. As for the type of the nodules,
they were defined as solid when the solid component was
greater than 70%, mixed when the solid component was
lesser than 70% and greater than 30%, and cystic when the
solid component was less than 30%. Vascularity was eval-
uated according to a five-point scale, where 0 is defined as
no visible flow, 1 as peripheral flow only, 2 as peripheral
flow with a small amount of central flow, 3 as peripheral
flow plus extensive intranodular flow and 4 as central flow
only. Therapeutic success was defined as a volume reduction
greater than 50%.
Figure 1. Flow chart of patient selection.
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RFA and surgical techniques
RFA. All RFA procedures were performed by the same radi-
ologist in an outpatient regimen. After local anesthesia at
the puncture site (2% lidocaine hydrochloride), the electrode
was inserted under US-guidance into the thyroid nodule
with a transisthmic approach (whenever possible). For the
procedures, we used a radiofrequency generator (AMICA RF
generator) and 18-gauge internally cooled electrodes with a
0.7–1.0–1.5 cm active-tip (Amica probes, HS AMICA). All RFA
were performed with the moving-shot technique [24].
Ablation was begun with 30W of radiofrequency power,
starting from the deepest areas of the nodule. If a hypere-
choic zone had not formed at the electrode tip within
5–10 s, radiofrequency power was progressively increased in
10W steps up to 60W. Ablation was terminated when transi-
ent hyperechoic zones could be identified around the
whole nodule.
Surgery. All operations were carried out by the same
team, which included two surgeons (lead and assistant sur-
geon). These operations were carried out in an inpatient
regimen. Hemithyroidectomy was performed by a single
access of 2–5 cm in the middle area of the neck, approxi-
mately 2 cm above the sternal notch. Patients, under general
anesthesia, were placed in the supine position with the neck
extended. Minimal subplatysmal flaps were created. The mid-
line was incised and the strap muscles were retracted lat-
erally. The vessels of the upper thyroid peduncle were
selectively ligated or closed by conventional vascular clips or
other devices. Special care was taken to preserve the para-
thyroid glands and the inferior laryngeal nerve. Once the thy-
roid lobe and isthmus had been removed, the area was
examined for bleeding. If there was no bleeding, the incision
was closed with sutures. In some cases, a surgical drain was
placed to remove fluids from the area in the following days.
Finally, anesthesia was discontinued and medication was
given to wake the patient.
Telephone survey
Telephone surveys are used widely in public health research
internationally [25]; given this vast use, we have herein
employed such a method to investigate patient satisfaction
after undergoing thyroid nodule treatment. Between April
and August 2017, all the patients selected were contacted by
phone call by the same interviewer, who was an undergradu-
ate medical student. Based on a script, patients were
informed about the nature of the survey and the organiza-
tion carrying it out, and they were asked the same four ques-
tions. These were (1) Are you satisfied with the resolution of
nodule-related symptoms?; (2) Are you satisfied with the cos-
metic results?; (3) Are you satisfied overall with the proced-
ure?; and (4) Are you taking any medication for your thyroid?
After each of the first three questions, patients were given
three options as possible answers: yes, partially and no.
When interviewed about the resolution of nodule-related
symptoms, they could also answer that they had never had
symptoms. As for thyroid medications, they were asked an
open question and their answers were coded as levothyrox-
ine, antithyroid drugs or no medication. The script of this
questionnaire has been developed taking into account that:
1) telephone survey must be concise, otherwise answers
might be affected by consumer fatigue [25]; and 2) questions
had to fit patients who had been treated with two vastly dif-
ferent approaches.
Statistical analysis
Quantitative (continuous) variables are reported as
mean± SD. Qualitative (categorical) variables are reported as
absolute frequencies and/or percentages. Continuous varia-
bles were compared by student's t test or by Mann–Whitney
test, depending on data distribution (parametric or non-para-
metric, respectively). In order to control potential confound-
ing effects and selection bias and to assure that groups were
comparable, we performed a sensitivity analysis using pro-
pensity score matching with the R package ‘MatchIt’ (method
nearest neighbor) [26]. The patients were matched 1:1 by
age and type of nodule. The details of this analysis are
reported in the Supplementary material. Variations over time
of nodules’ volume were evaluated with linear mixed-effects
models (LME) for repeated measures and multiple compari-
sons of nodules’ volume respect to different follow-up peri-
ods (baseline vs 1, 12 and 24months) were performed with
Tukey’s post-hoc test. Categorical variables were compared
by Chi-square test or Fischer’s exact test whenever appropri-
ate. All statistical analyses were carried out in R system for
statistical computing (Ver. 3.3.2; R Development Core Team,
2016). Statistical significance was set at p< .05.
Results
Patient characteristics
Patients did not differ in terms of sex, nodule volume and
vascularity, thyroid function, autoimmunity and calcitonin
(Table 1). On the other hand, patients treated with RFA were
older, which is consistent with the fact that RFA was initially
Table 1. Patients’ characteristics at baseline.
Variable RFA (115) hEMItx (68) p Value
Age (years) 59.2 ± 14.8 51.1 ± 14.6 .002
Sex
M 28 (24.3%) 14 (20.6%) .64
F 87 (75.7%) 54 (79.4%)
Volume (mL) 18.0 ± 16.1 16.5 ± 13.2 .54
Type of nodule
Solid 80 (69.6%) 27 (39.7%) <.001
Mixed 28 (24.3%) 27 (39.7%)
Cystic 7 (6.1%) 14 (20.6%)
Vascularity
0 4 (3.5%) 7 (13.0%) .05
1 41 (35.7%) 21(38.9%)
2 48 (41.7%) 22 (40.7%)
3 17 (14.8%) 4 (7.4%)
4 5 (4.3%) 0 (0%)
TSH (microU/mL) 1.2 ± 1.4 2.4 ± 6.9 .92
Calcitonin (pg/mL) 1.4 ± 1.1 1.7 ± 3.2 .30
Ab
Negative 100 (87.0%) 58 (85.3%)
Positive 15 (12.8%) 10 (14.7%) .72
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used to treat patients with contraindications to surgery
[27,28], those of whom are generally older. In addition, in
the RFA group, there was a lower percentage of cystic nod-
ules (Table 1). This is consistent with the fact that when
patients with cystic nodules preferred a non-surgical treat-
ment, they were initially treated with percutaneous ethanol
injection, which should be the first-line treatment in this
case [3,4]. Only if clinical problems were incompletely
resolved after ethanol ablation were patients then treated
with RFA [29,30]. Having said that, age and type of nodule
did not affect our results, as shown with a propensity score-
matching (Supplementary material) [26].
Thyroid nodule features after RFA
In this study, the patients who underwent RFA had been fol-
lowed for 33.7 ± 14.6months. Follow-up revealed that RFA
significantly reduced thyroid nodule volume, as shown in
Table 2. In particular, the nodules’ volume decreased linearly
with time (p< .001 Linear Mixed-Effects model for repeated
measures) being 18.0 ± 16.1ml at baseline, 9.4ml ±10.1ml
after 1month from the procedure, 5.1 ± 6.7ml after
12months and 4.7 ± 8.4ml after 24months. In other words,
the volume decreased by 46%, 74% and 76% at 1, 12 and
24months after RFA, respectively. Therapeutic success was
achieved with a single session in 111 out of 115 patients,
while 4 patients required two sessions (average number of
sessions per patient was 1.03 ± 0.17).
When looking at the subgroups of patients with nonfunc-
tioning thyroid nodules (83 patients) and AFTN (32 patients)
who were treated with RFA, nodular volume decreased lin-
early with time in both cohorts (p< .001, Linear Mixed-
Effects model for repeated measures), as shown in Table 2.
In the subgroup of patients with nonfunctioning thyroid
nodules, 3 patients underwent 2 sessions of RFA and the
average number of sessions per patient was 1.04 ± 0.19. In
the subgroup of patients with AFTN, 1 patient underwent 2
sessions of RFA and the average number of sessions per
patient was 1.03 ± 0.18.
Patient satisfaction
Resolution of nodule-related symptoms. From the first set of
pie charts (Figure 2(A)), it can be seen that the majority of
the patients in both the RFA and surgery group answered
that they were fully satisfied with the symptom resolution.
The percentage of patients who were asymptomatic prior to
the procedure did not differ between the groups (p¼ .56),
being 19% in the RFA and 23.5% in the surgery group. If we
excluded the patients that were asymptomatic, the percentage
of patients fully satisfied in the surgery group (96%) became
significantly higher as compared to RFA (81%; p¼ .02).
Conversely, the percentage of patients only partly satisfied was
significantly higher in the RFA group (18%) than in the surgery
group (4%; p¼ .03), as shown in Figure 2(A).
Cosmetic results. In the RFA group, there was a signifi-
cantly higher percentage of patients fully satisfied with the
cosmetic results (92%) as compared to the surgery group
(69%; p¼ .001), as shown in Figure 2(B). Conversely, in the
surgery group, there was a higher percentage of patients
who were only partially satisfied (p¼ .01) or not satisfied
with the cosmetic results (p¼ .004), as shown in Figure 2(B).
Overall satisfaction. There were no differences in terms of
overall satisfaction between the groups. Surgery was associ-
ated with a tendency towards a greater percentage of
patients fully satisfied, which, however, was not statistically
significant (p¼ .26), as shown in Figure 2(C).
Subgroup analysis
Nonfunctioning thyroid nodules. It has been argued that the
best candidate for thyroid RFA is a single, cold, benign,
symptomatic thyroid nodule [5] and that RFA might be not
as effective in AFTN [2,17]. Based on these premises, we car-
ried out a subgroup analysis and looked at patient satisfac-
tion in the subgroup of subjects with nonfunctioning thyroid
nodules and in that of subjects with AFTN. In the subgroup
of patients with nonfunctioning thyroid nodules, the majority
answered that they were fully satisfied with the symptom
resolution after both procedures (Figure 3(A)). The percentage
of patients who were asymptomatic prior to the procedure did
not differ between the groups (p¼ .26), being 13.3% in the RFA
and 22.7% in the surgery group. If we excluded the patients
that were asymptomatic, the percentage of patients fully satis-
fied in the surgery group (94.1%) did not significantly differ
from the RFA group (81.9%; p¼ .16). Regarding the cosmetic
results (Figure 3(B)), there was a significantly higher percentage
of patients in the RFA group that were fully satisfied with the
cosmetic results (90%) as compared to the surgery group (68%;
p¼ .004). Conversely, there was a higher percentage of patients
in the surgery group who were not satisfied with the cosmetic
results (p¼ .02 vs RFA), as shown in Figure 3(B). There were no
differences in terms of overall satisfaction between the two
groups Figure 3(C).
Autonomously functioning thyroid nodules. It is in patients
with AFTN that RFA was not as fully satisfactory as surgery
with respect to the resolution of nodule-related symptoms
(Figure 4(A)). If we excluded the patients that were asymp-
tomatic, the percentage of patients fully satisfied with RFA
was 76% as compared to the surgery group where the rate
was 100% (p< .05). The percentage of patients partially satis-
fied did not differ between the groups. Regarding the cos-
metic results, in the RFA group, there was a significantly
higher percentage of patients fully satisfied with the cos-
metic results (97%), as compared to the surgery group (71%;
p¼ .02), as shown in Figure 4(B). There were no differences
Table 2. Nodule volume reduction after RFA.
Baseline 1 month 1 year 2 years p Value
All nodules
Patients (115) (115) (115) (94)
Volume (mL) 18.0 ± 16.1 9.4 ± 10.1 5.1 ± 6.7 4.7 ± 8.4 <.001
Nonfunctioning thyroid nodules
Patients (83) (83) (83) (66)
Volume (mL) 18.3 ± 17.2 9.9 ± 11.4 5.5 ± 7.7 5.3 ± 9.8 <.001
Autonomously functioning thyroid nodules
Patients (32) (32) (32) (28)
Volume (mL) 16.9 ± 12.8 8.3 ± 5.8 3.9 ± 3.1 3.5 ± 3.4 <.001
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in terms of overall satisfaction between the two groups, as
shown in Figure 4(C).
Complications
Consistent with the literature [31], in the RFA group, two
patients had a major complication (1.7%). These were one
case of voice change that lasted more than 1month and one
case of third-degree skin burn. Moreover, three patients had
a minor complication (2.6%). These were two cases of voice
change that lasted less than 1month and one case of late-
onset thyroiditis with thyrotoxicosis. Thus, in the RFA group,
the rate of overall complications was 4.3% (5 patients out of
115). In the hEMItx group, the rate of overall complications
was 10.3% (7 patients out of 68). The majority of them had a
voice change due to a transient unilateral vocal cord palsy (5
out of 7), while the remaining patients had a transient hypo-
calcemia (1 out of 7) and a wound complication (1 out of 7).
The groups did not significantly differ in terms of complication
rate (p¼ .13). Nevertheless, in the surgery group, 28 patients
out of 68 (41.1%) became hypothyroid and started taking levo-
thyroxine after the procedure. If we included the prevalence of
postoperative hypothyroidism, which is an occurrence that
increases the level of care and requires medication, there was a
significant difference in the complication rate following RFA vs
Figure 2. Survey outcome in all patients. Patients included 115 subjects treated with RFA and 68 subjects treated with surgery. (A) Pie charts representing the dis-
tribution of the answers ‘yes’, ‘partially’ and ‘no’ to the question: ‘Are you satisfied with the resolution of nodule-related symptoms?’. Upper panel: pie charts that
include asymptomatic patients; lower panel: pie charts that exclude asymptomatic patients. (B) Pie charts representing the distribution of the answers ‘yes’,
‘partially’ and ‘no’ to the question: ‘Are you satisfied with the cosmetic results?’. (C) Pie charts representing the distribution of the answers ‘yes’, ‘partially’ and ‘no’
to the question: ‘Are you satisfied overall with the procedure?’.
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surgery, as the surgery group became significantly higher in
complications (p¼ .001).
Thyroid function and medication in patients with AFTN
The percentage of patients with AFTN was the same in both
groups, being 28% in the RFA group and 35% in the hEMItx
group (p¼ .29). Among these patients, surgery was more
effective than RFA in terms of resolution of a hyperthyroid
state without the need of antithyroid drugs (p¼ .002 vs RFA).
After surgery, almost all patients (95.8%) withdrew from
antithyroid drugs except for one (4.2%), who continued tak-
ing methimazole afterwards. On the other hand, RFA was
effective in 18 patients out of 34 (52.9%), and the remaining
16 patients (47.1%) had to continue with methimazole.
Nevertheless, RFA did not cause hypothyroidism, while 37.5%
of surgery patients (9 patients out of 24) started taking levo-
thyroxine after surgery. Overall, there were no differences
between the two groups in terms of patients who kept tak-
ing medication after each procedure (p¼ .55), being 47.1% in
the RFA group and 41.7% in the surgery group.
Discussion
While we are entering the era of interventional thyroidology
[5,12,27], surgery remains the first-line therapy for most
Figure 3. Survey outcome in the subgroup of patients with nonfunctioning thyroid nodules. Patients included 83 subjects treated with RFA and 44 subjects treated
with surgery. (A) Pie charts representing the distribution of the answers ‘yes’, ‘partially’ and ‘no’ to the question: ‘Are you satisfied with the resolution of nodule-
related symptoms?’. Upper panel: pie charts that include asymptomatic patients; lower panel: pie charts that exclude asymptomatic patients. (B) Pie charts repre-
senting the distribution of the answers ‘yes’, ‘partially’ and ‘no’ to the question: ‘Are you satisfied with the cosmetic results?’. (C) Pie charts representing the distri-
bution of the answers ‘yes’, ‘partially’ and ‘no’ to the question: ‘Are you satisfied overall with the procedure?’.
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patients with symptomatic benign thyroid nodules [13]. In
this study, we compared RFA to surgery in terms of patient
satisfaction. Overall, the vast majority of our patients who
underwent surgery were fully satisfied with the outcome
(94%). This is in line with the observation that thyroid sur-
gery profoundly improves patient overall quality of life [32].
Thyroid surgery has clear advantages over any other tech-
nique. It represents a definitive solution to a symptomatic
thyroid nodule. Moreover, it does not only relieve from local
symptoms and/or remove an AFTN, but it can exclude malig-
nancy. In this study, it is likely that the vast majority of our
patients were fully satisfied after being operated on (94%)
because surgery relieved them fully from nodule-related local
symptoms (96%), and/or hyperthyroidism (95.8%). On the
other hand, however, the price that is paid for such a treat-
ment includes postoperative hypothyroidism, a neck scar,
and a rate, albeit low, of other complications, such as laryn-
geal nerve injury, hypoparathyroidism, postoperative bleed-
ing and wound infection [33].
Minimally invasive techniques, and among them thyroid
RFA, represent a promising therapeutic alternative to surgery
that allow to avoid its drawbacks [34]. The efficacy and safety
of thyroid RFA have been demonstrated in several studies
[17]. In particular, in a recent randomized controlled trial
where RFA was compared to observation, RFA significantly
reduced the volume of benign thyroid nodules, such that
Figure 4. Survey outcome in the subgroup of patients with autonomously functioning thyroid nodules. Patients included 32 subjects treated with RFA and 24 sub-
jects treated with surgery. (A) Pie charts representing the distribution of the answers ‘yes’, ‘partially’ and ‘no’ to the question: ‘Are you satisfied with the resolution
of nodule-related symptoms?’. Upper panel: pie charts that include asymptomatic patients; lower panel: pie charts that exclude asymptomatic patients. (B) Pie
charts representing the distribution of the answers ‘yes’, ‘partially’ and ‘no’ to the question: ‘Are you satisfied with the cosmetic results?’. (C) Pie charts representing
the distribution of the answers ‘yes’, ‘partially’ and ‘no’ to the question: ‘Are you satisfied overall with the procedure?’.
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cosmetic and compressive symptoms significantly improved
after the procedure, without relevant side effects [35]. To our
knowledge, only three studies have compared surgery to
RFA [14–16], suggesting that RFA was not inferior to surgery
in nonfunctioning benign thyroid nodules [14], and that it
was even superior in terms of complications [15] and post-
procedure health-related quality of life (HRQoL) [16]. In par-
ticular, the group of Yue, who assessed HRQoL, showed that
it significantly improved after 6months from both surgery
and RFA, but that patients who had been treated with RFA
had better HRQoL as compared to those surgically treated.
Nevertheless, the same authors argued that these differences
could have disappeared over time, as HRQoL of patients that
are operated on take some time to convalesce after sur-
gery [36].
At a first glance, our data seemed to challenge the con-
cept that RFA and surgery are equal in terms of clinically effi-
cacy. When comparing all the patients, surgery was found
more effective than RFA in terms of satisfaction with the
resolution of nodule-related symptoms, as well as with the
cure of hyperthyroidism. This is consistent with the ATA rec-
ommendation [13] to choose surgery as the preferred thera-
peutic option for a patient with a symptomatic benign
thyroid nodule, and the concept that RFA should be taken
into account in case of refusal or contraindications to it [28].
Nevertheless, when we looked at the rate of satisfaction with
the resolution of nodule-related symptoms in the subgroups
of patients with nonfunctioning thyroid nodules and with
AFTN, we found that RFA led to different results based on
thyroid nodule function. In patients with nonfunctioning thy-
roid nodules, RFA was actually as effective as surgery in
terms of satisfaction with the resolution of nodule-related
symptoms, while it was not in patients with AFTN. This is in
line with our previous work, in which we analyzed the out-
comes of patients treated by RFA to those who underwent
hemithyroidectomy and found that both techniques were
equally effective for treating nodule-related clinical problems,
with the exception being patients with an initial nodular vol-
ume greater than 35ml and AFTN [14], where surgery should
be still preferred. This is also in line with the literature sug-
gesting that the best results from RFA appear to be limited
to small and, partially, medium nonfunctioning thyroid nod-
ules [5,8].
Interestingly, in this study, both RFA and surgery had a
similar overall satisfaction score. One reason accounting for
the high percentage of patients who were overall fully satis-
fied after RFA – also in the AFTN subgroup – is that patient
satisfaction is multidimensional. It includes more aspects
than local symptom relief or hyperthyroidism control. It has
recently been argued that modern medicine should aim not
only to treat the relevant disease, but also to take care of
the patient as a whole [34]. For example, although RFA does
not completely remove the nodule, it has the advantage of
not leaving any scar. Consistent with this outcome, patient
satisfaction with the cosmetic results was greater in the RFA
than the surgery group. Second, RFA does not cause hypo-
thyroidism, has a low rate of complications [37], and post-
procedural pain is rare [37]. In this study, the rate of
complications after RFA was lower than after surgery, and
41.1% of the patients surgically treated had to take levothyr-
oxine. Finally, RFA is an outpatient procedure, which does
not require general anesthesia and hospitalization days. We
speculate that it must have been for these reasons that, in
the subgroup of patients with AFTN, the rate of patients
overall fully satisfied with RFA was similar to surgery.
For this cross-sectional survey, patients were selected
from our database. Although RFA and surgery had been car-
ried out at different times before the survey, we made sure
that all patients had been treated at least one year prior to
it, as postsurgical complications might need one year to
recover [38]. Certainly, in some patients survey point was far
from initial surgery, which should be taken into account
when looking at our data. Having said that, the strengths of
this study include the homogeneity of treatments (patients
were treated by the same radiologist or surgeon) and of
interviews, which were carried out by the same neutral per-
son. Regarding telephone surveys, their strength is that they
allow to collect data of a sensitive nature because respond-
ents gain perceived anonymity [25]. On the other hand,
these kinds of surveys have some limitations. First, they must
be concise, and therefore less detailed than other question-
naires. Second, a growing percentage of patients refuses to
participate due to the recent phenomenon of consumer
fatigue [25]. These are the reasons underlying the choice of
this questionnaire. Nevertheless, given that this survey had
not been validated before it was used, further larger studies
with validated surveys are needed to confirm our data and
look into postoperative patient satisfaction.
In conclusion, our results on postoperative patient satis-
faction show that RFA and surgery were both desirable for
the patients and support the notion that both RFA and sur-
gery are valid first-line therapeutic options in case of benign
nonfunctioning thyroid nodules. On the other hand, given
that the percentage of patients with AFTN that were fully
satisfied over symptom resolution was lower after RFA than
after surgery, this study suggests that surgery should be still
the preferred first-line therapeutic option in this subgroup
of patients.
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